| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $887K | -26.2% | -44.8% |
| R&D Expense | $5.2M | +6.8% | +45.4% |
| SG&A Expense | $10.0M | -2.2% | +24.9% |
| Operating Income | -$19.9M | -15.2% | -43.4% |
| Pre-tax Income | $529K | +100.8% | +103.9% |
| Income Tax | $46K | +9.5% | +76.9% |
| Net Income | $483K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $90.0M | +52.9% | +32.5% |
| Short-term Investments | $77.6M | -33.8% | +311.3% |
| Accounts Receivable | $1.4M | -36.0% | -35.9% |
| Current Assets | $172.3M | -5.3% | +65.0% |
| Total Assets | $263.1M | +2.5% | +53.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$34.7M | — | — |
| Capital Expenditures | $65K | — | — |
| Investing Cash Flow | -$35.0M | — | — |
| Financing Cash Flow | $120.1M | — | — |
| Free Cash Flow | -$34.7M | — | — |
| +100.8% |
| +103.5% |
| EPS (Basic) | $0.00 | +100.0% | +100.0% |
| EPS (Diluted) | -$0.12 | +75.0% | -9.1% |
| $14.9M |
| +22.8% |
| -28.3% |
| Long-term Debt | $230.1M | -6.6% | +334.4% |
| Total Liabilities | $285.2M | -6.2% | +168.8% |
| Stockholders' Equity | -$22.1M | +53.2% | -133.7% |